Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Celanese Corporation (CE)’s Fourth Quarter 2014 Earnings Conference Call Transcript

Below is transcript of the Celanese Corporation (NYSE:CE)’s Fourth Quarter 2014 Earnings Conference Call, held on January 23, 2015, at 10:00 a.m. ET. Gmt Capital, Mountain Lake Investment Management and Private Capital Management was among Celanese Corporation (NYSE:CEshareholders at the end of the third quarter.


Celanese Corporation (NYSE:CE)


Celanese Corporation (NYSE:CEmanufactures chemical products. The Company’s portfolio consists of five main businesses: Acetyl Products, Chemical Intermediates, Acetate Products, Technical Polymers Ticona and Performance Products. Celanese has 29 production plants, with major operations in North America, Europe and Asia. The Company integrates CoolPoly E-Series, CoolPoly D-Series and CoolPoly Elastomers into its engineered materials portfolio.


Company Executives:

Jon Puckett – Vice President, Investor Relations, Celanese Corporation
Mark Rohr – Chairman and CEO, Celanese Corporation
Christopher Jensen – SVP, Finance and Interim CFO, Celanese Corporation



Duffy Fisher – Barclays Capital, Inc.
David Begleiter – Deutsche Bank
Laurence Alexander – Jefferies & Co., Inc.
John McNulty – Credit Suisse
PJ Juvekar – Citigroup Investment Research
Frank Mitsch – Wells Fargo Securities
Cooley May – Macquarie Research
Kevin McCarthy – Bank of America Merrill Lynch
Bob Koort – Goldman Sachs
Vincent Andrews – Morgan Stanley



Good morning, and welcome to the Celanese Fourth Quarter 2014 Earnings Conference Call. All participants will be in listen-only mode. After today’s presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Jon Puckett. Please go ahead.


Jon Puckett, VP, IR

Thanks Drew. Welcome to the Celanese Corporation Fourth Quarter 2014 Conference Call. My name is Jon Puckett, Vice President of Investor Relations. With me today are Mark Rohr, Chairman and Chief Executive Officer and Chris Jensen, Senior Vice President, Finance. The Celanese Corporation fourth quarter 2014 earnings release was distributed via Business Wire yesterday after market close. The slides for the call and our prepared comments for the quarter were also posted on our website,, in the Investor Relations section. As a reminder, some of the matters discussed today and included in our presentations may include forward-looking statements concerning, for example, Celanese Corporation’s future objectives and results. Please note the cautionary language contained in the posted slides.

Read the rest of this transcript on

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!